Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-072379
Filing Date
2024-06-17
Accepted
2024-06-17 17:20:35
Documents
17
Period of Report
2024-06-17
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2416775d1_8ka.htm   iXBRL 8-K/A 30749
2 EXHIBIT 23.1 tm2416775d1_ex23-1.htm EX-23.1 6079
3 EXHIBIT 99.1 tm2416775d1_ex99-1.htm EX-99.1 247729
4 EXHIBIT 99.2 tm2416775d1_ex99-2.htm EX-99.2 177091
5 EXHIBIT 99.3 tm2416775d1_ex99-3.htm EX-99.3 176074
  Complete submission text file 0001104659-24-072379.txt   889648

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tmb-20240617.xsd EX-101.SCH 3012
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20240617_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20240617_pre.xml EX-101.PRE 22358
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2416775d1_8ka_htm.xml XML 4066
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36020 | Film No.: 241049322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)